Proving the Potential: What Happens When Phage Therapy Reaches the Bedside
- Sharing outcomes from Queen Astrid Military Hospital-based phage framework, which has delivered personalised treatments to more than 225 patients across 15 bacterial species
- Illustrating how direct clinical access to tailored phages is transforming outcomes for patients with otherwise untreatable infections
- Reflecting on lessons from expanding these efforts internationally, including collaborations in regions facing rising AMR, to show how pragmatic access models can drive real patient impact worldwide